- Trials with a EudraCT protocol (33)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (33)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: Local anesthetic efficacy for oral surgery. Comparison of diphenhydramine and prilocaine, Uckan, S., Oral surgery, oral medicine, oral pathology 1998; 86(1): 26-30Local anesthetic efficacy for oral surgery. Comparison of diphenhydramine and prilocaine, Uckan, S., Oral surgery, oral medicine, oral pathology 1998; 86(1): 26-30 |
| Active substance: DIPHENHYDRAMINE_OR DIPHENHYDRAMINE AND CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26226 |
| Study title: |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 02_3-EML-06 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47224 |
| Study title: |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 03_89 EM 01 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47225 |
| Study title: |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 04_85-EM 24 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47226 |
| Study title: A clinical study of plasma concentrations of lidocaine and prilocaine and methaemoglobin formation after dermal application of EMLA in infants. (Part B) |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 20_85-EM09 (Part B) CSR Synopsis.pdf |
| View full study record |
| Document reference: 31240 |
| Study title: A clinical study of plasma concentrations of lidocaine and prilocaine and methaemoglobin formation after dermal application of EMLA in infants. (Part B) |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 20_85-EM09 (Part B) CSR Synopsis.pdf |
| View full study record |
| Document reference: 47238 |
| Study title: A clinical study of the plasma concentrations of lidocaine, prilocaine and methaemoglobin formation after dermal application of EMLA in infants. (Part C) |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 21_85-EM09 (Part C) CSR Synopsis.pdf |
| View full study record |
| Document reference: 47237 |
| Study title: A double-blind parallel group study comparing EMLA cream 5% with placebo in capillary blood sampling of neonates |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 15_AG-EML-002 (87EM10) CSR Synopsis.pdf |
| View full study record |
| Document reference: 47243 |
| Study title: A randomized, double-blind, placebo-controlled trial to measure the antibody response to immunisation with diphtheria-tetanus-pertussis-inactivated poliovirus-haemophilus influenzae b and hepatitis B vaccines using |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 14_DC-EMB-0002 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47244 |
| Study title: A randomized, double-blind, placebo-controlled trial to measure the antibody response to immunization with measles-mumbs-rubella vaccines using EMLA patch for the reduction of pain associated with subcutaneous injection in twelve month old infants, 1998 |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 13_DC-EMB-0001 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47245 |
| Study title: Analgesia for the surgical removal of molluscum contagiosum in children: a double-blind, placebo-controlled, time-repsonse study of EMLA(R) (lidocaine/prilocaine) cream. Astra Report 802-10 AC 082-1, February 05, 1990. |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 06_86EM25 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47251 |
| Study title: Astra Report A randomized, open label, comparative parallel group study to evaluate the efficacy and safety of EMLA® Cream and 1% Xylocaine® infiltration in males for relief of pain associated with the removal of genital warts by cryotherapy. |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 11_93-EML-18 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47247 |
| Study title: Astra Report No 802 10 AC 093-1 A Clinical Study On A Single Unit Dose Package of Emla (Emla Patch) and Emla 5% Cream Used to Reduse Pain From Venupuncture in Children. |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 24_89 EM 04 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47236 |
| Study title: Astra Report No 802-10 AC 064-1 Local anaesthesia with EMLA Cream for cautery of condylomata acuminata of the genital mucosa in women - effect of application time. 86EM04 (Part I) |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 09_86-EM04 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47249 |
| Study title: Astra Report No. 802-10 AC 062-1 Local Anaesthesia with Emla Cream for Laser Treatment of Condylomata Acuminata in Women. A Double-blind Comparison with Placebo to Evaluate the Time of Onset and Duration of Anaesthesia of the Genital Mucosa. 86EM07 |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 10_86-EM07 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47248 |
| Study title: Astra Report No. 802-10 AC 094 Clinical Study On Two Single Unit Dose Packages (Emla Patch) and Emla 5 % Cream Used to Reduce Pain at I.V Cannulation in Children |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 29_88EM01 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47231 |
| Study title: Biometrical analysis of a controlled double-blind crossover study on 48 patients. EMLA vs Placebo WG85EM01 (Astra Study 802-10 AC 068-1) |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 25_85-EM01 (WG85EM01) CSR Synopsis.pdf |
| View full study record |
| Document reference: 47235 |
| Study title: Determination of a minimum application time for efficacy of a 5% lidocaine-prilocaine cream, EMLA (Eutectic Mixture of Local Anaesthetics), used for relief of venipuncture pain in children. Astra Report 802-10 AC 015-2, March 31, 1983. |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 07_81PO34 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47250 |
| Study title: Double-blind evaluation of a lidocaine-prilocaine cream (EMLA) for venous cannulation pain in children |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 31_83-P029 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47229 |
| Study title: EMLA cream 5% for removal of mollusca. A clinical study of plasma concentrations of lidocaine and prilocaine and analgesic effect in children. |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 19_86EM13 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47239 |
